Companies /Healthcare

Turn Therapeutics Inc. Common Stock

NASDAQ: TTRX Biotechnology
$12.69
▼ $0.69 (−5.16%) today
Markets closed · 4:43am ET
Today · % change

Fundamentals

Market Cap
$385.4M
EPS (TTM)
$-0.28
52-Week Range
$3 – $14
Street Target
$26.00

About TTRX

Turn Therapeutics Inc. (Ticker: TTRX) is a forward-thinking pharmaceutical company headquartered in Westlake Village, California, dedicated to pioneering innovative therapies for skin, nail, and ocular diseases. By harnessing state-of-the-art research and technology, the company targets significant unmet medical needs in these specialty areas, aiming to deliver transformative treatments that enhance patient outcomes. With a strong commitment to improving the quality of life for patients suffering from chronic conditions, Turn Therapeutics is well-positioned to make impactful contributions to the healthcare landscape.

TTRX Coverage